Reduced Calf Muscle Pump Function Is Not Explained by Hand Grip Strength Measurements.

Hand Strength calf muscle pump dynamometer plethysmography

Journal

Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771

Informations de publication

Date de publication:
07 Mar 2024
Historique:
received: 17 11 2023
revised: 28 02 2024
accepted: 01 03 2024
medline: 10 3 2024
pubmed: 10 3 2024
entrez: 9 3 2024
Statut: aheadofprint

Résumé

Reduced calf muscle pump function (CPF) is an independent risk factor for venous thromboembolism and mortality. We aimed to evaluate the relationship between hand grip strength (HGS) and CPF. Patients referred to the Gonda Vascular Laboratory for non-invasive venous studies were identified and consented. Subjects underwent standard venous air plethysmography protocol. CPF (ejection fraction) was measured in each lower extremity of ambulatory patients by comparing refill volume after ankle flexes and passive refill volumes. The cut-off for reduced calf pump function (rCPF) was defined as an ejection fraction below 45%. Maximum HGS bilaterally was obtained (3 trials per hand) using a dynamometer. HGS and CPF were compared (right hand to calf, left hand to calf) and the correlation between the measures was evaluated. 115 patients (mean age 59.2 (SD 17.4) years, 67 females, mean BMI 30.83 (SD, 6.46)) were consented and assessed for HGS and CPF. Reduced CPF was observed in 53 (46%) right legs and 67 (58%) left legs. CPF was reduced bilaterally in 45 (39%) and unilaterally in 30 (26%) subjects. HGS was reduced bilaterally in 74 (64.3%), unilaterally reduced in 23 (20%), and normal in 18 (15.7%) subjects. Comparing each hand/calf pair, no significant correlations were seen between HGS and CPF. The Spearman's rank correlation coefficients test yielded values of 0.16 for the right side and 0.10 for the left side. There is no significant correlation between HGS and CPF, demonstrating that HGS measurements are not an acceptable surrogate for rCPF indicating different pathophysiologic mechanisms for each process.

Identifiants

pubmed: 38460817
pii: S2213-333X(24)00160-4
doi: 10.1016/j.jvsv.2024.101869
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101869

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Atefeh Ghorbanzadeh (A)

Department of Cardiovascular Diseases, Division of Vascular Medicine, Mayo Clinic, Rochester, MN;; Gonda Vascular Center, Mayo Clinic, Rochester, MN.

Abdi Abud (A)

University of Missouri-Columbia School of Medicine, Columbia, MO.

David Liedl (D)

Gonda Vascular Center, Mayo Clinic, Rochester, MN.

Thom Rooke (T)

Department of Cardiovascular Diseases, Division of Vascular Medicine, Mayo Clinic, Rochester, MN;; Gonda Vascular Center, Mayo Clinic, Rochester, MN.

Paul Wennberg (P)

Department of Cardiovascular Diseases, Division of Vascular Medicine, Mayo Clinic, Rochester, MN;; Gonda Vascular Center, Mayo Clinic, Rochester, MN.

Waldemar Wysokinski (W)

Department of Cardiovascular Diseases, Division of Vascular Medicine, Mayo Clinic, Rochester, MN;; Gonda Vascular Center, Mayo Clinic, Rochester, MN.

Robert McBane (R)

Department of Cardiovascular Diseases, Division of Vascular Medicine, Mayo Clinic, Rochester, MN;; Gonda Vascular Center, Mayo Clinic, Rochester, MN.

Damon E Houghton (DE)

Department of Cardiovascular Diseases, Division of Vascular Medicine, Mayo Clinic, Rochester, MN;; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN,; Gonda Vascular Center, Mayo Clinic, Rochester, MN,. Electronic address: Houghton.Damon@mayo.edu.

Classifications MeSH